Page 69 - MBCA_FULL REPORT_FINAL_FOR_WEB
P. 69

Surveys indicate that MBC patients strongly desire better communication with their HCPs.
            They would like to feel cared for and respected as persons, not just patients, and to have their
            concerns heard and the challenges they face understood. Areas much in need of improvement
            are continuity and coordination of care; patient-friendly office procedures and hours, including
            less waiting time, timely test results, and better access to staff when the office is closed. Also
            needed are higher-quality patient education and disclosure to facilitate treatment decision
            making, more time with providers to address patient concerns, and referrals to second
            opinions and specialists [57, 79] .

            An overwhelming majority of surveyed patients with MBC are either currently undergoing an
            anticancer treatment or are in the process of changing treatments after disease progression.   People diagnosed
            When asked, very few survey participants say they prefer to “live out the time they have   with MBC  would like
            peacefully, without treatment” [3, 57] .                                             to feel cared for and
                                                                                                 respected as persons,
            When asked, MBC patients have many concerns about the treatment they receive, some of   not just patients,
                                                                                                 and to have their
            which could be addressed through better communication with HCPs. They express frustration   concerns heard and
            at the trial-and-error nature of treatment, seek less toxicity, and are eager for biomarkers   the challenges they
            predictive of treatment benefit. When asked about the risk-to-benefit “trade-off” of treatment,   face understood.
            MBC patients show a willingness to tolerate significant toxicity in exchange for possible benefit,
            such as longer survival or even a modest delay in progression of their disease [79-81] . However,
            symptom severity is also of concern to them, and treatment choices may vary by stage of
            life—for example, whether or not children are still at home [80] .

            We did not review the extensive literature on communication issues with physicians, patients,
            and families surrounding end-of-life choices, as the focus of our analysis is living with MBC. But
            it is never too soon for MBC patients to establish lines of frank and open communication with
            their treating physicians, as a full discussion of the goals of treatment is central to quality of
            cancer care as well as quality of life.































                                                                                                                69
   64   65   66   67   68   69   70   71   72   73   74